What is Medicina?
Medicina operates as a specialized leader in the development and distribution of ENFit enteral delivery systems. The company provides a comprehensive suite of medical components, including ENFit syringes, feeding tubes, and essential accessories tailored for both neonatal and adult patient populations. By focusing on the integration of safer enteral access, Medicina addresses a critical need in modern healthcare environments. Their business model emphasizes not only clinical efficacy but also significant cost advantages, allowing healthcare institutions to optimize their procurement of essential medical supplies without compromising on quality or patient safety standards.
How much funding has Medicina raised?
Medicina has raised a total of $9.8M across 1 funding round:
Unspecified
$9.8M
Unspecified (2013): $9.8M with participation from Business Growth Fund
Key Investors in Medicina
Business Growth Fund
BGF is a prominent London-based investment firm recognized as the most active backer of small and mid-sized businesses in the UK, providing long-term capital to support growth across diverse economic sectors.
What's next for Medicina?
With this major strategic investment, Medicina is well-positioned to accelerate its market penetration and enhance its product development pipeline. The company is expected to leverage these resources to expand its footprint in European markets, further refining its supply chain and distribution capabilities. As the healthcare industry continues to emphasize standardized safety protocols for enteral feeding, Medicina's commitment to ENFit compliance provides a distinct competitive advantage. Future growth will likely focus on scaling manufacturing capacity and deepening relationships with major hospital networks, ensuring that their innovative delivery systems remain at the forefront of clinical practice and patient safety initiatives.
See full Medicina company page
